Sleep Apnea: Diagnosis and Medical Management
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - North Carolina policy alerts
Know when Blue Cross Blue Shield - North Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
Coverage policy for diagnostic testing and non-surgical medical management of sleep apnea (adult and pediatric) including supervised polysomnography, home sleep apnea testing, CPAP/APAP, and oral appliances; applies to providers treating Blue Cross NC members.
No material clinical or coverage changes in this revision.
Coverage Criteria for Diagnostic Testing and Therapies
Supervised polysomnography (in-lab) — Diagnostic coverage
Covered when ALL of the following are met
In-lab polysomnography coverage
- Indications for supervised PSG: One or more of: pediatric individuals (<18 years); individuals who do not meet criteria for an unattended home sleep apnea test; prior home sleep apnea test failed to establish diagnosis or was technically inadequate; failure or recurrence of symptoms during treatment; testing to rule out other sleep disorders (eg, central sleep apnea, injurious parasomnias, narcolepsy); presence of comorbidity that might alter ventilation or reduce accuracy of HSAT (eg, heart failure, neuromuscular disease, chronic pulmonary disease, obesity hypoventilation syndrome).
Includes initiation/titration of CPAP in adults or children when AHI/RDI thresholds met per policy.
Home sleep apnea test (unattended) — Diagnostic coverage in adults
Covered when ALL of the following are met
HSAT may be used as a screening tool prior to bariatric surgery if no evidence of ventilatory-altering conditions.
Repeat unattended home sleep testing — Coverage
Covered when ANY of the following are met
Interpreter who bills the unattended study must meet sleep medicine qualifications (eg, ABSM certification, ABMS subspecialty certification, completed training awaiting exam, or active staff membership in an AASM- or Joint Commission-accredited sleep center).
Oral appliances — Coverage criteria
Covered when ALL of the following are met
Associated symptoms include a pre-treatment Epworth >10, impaired cognition, mood disorders, insomnia, hypertension, ischemic heart disease, or history of stroke.
CPAP/APAP — Coverage criteria
Covered when ONE of the following is met
APAP may be used during a 2-week trial to initiate/titrate CPAP in adults.
Pediatric thresholds and follow-up differ from adults; see pediatric criteria.
Split-night study can be used to titrate when AHI > 20 after initial hours per policy guidance.
CPAP failure/adherence requirements before alternatives
Covered when ALL of the following are met
Multiple visits to the sleep specialist during the acclimation period and documentation of ongoing management for two months or greater are expected.
Medical Management (Adult) — comprehensive coverage conditions and testing standards
Covered when the following clinical assessment and testing standards are met:
Provider interpreting studies should meet sleep medicine qualifications; documentation must include relevant symptom scores and testing details.
Oral Appliance Therapy
Oral appliance coverage conditions
Documentation must confirm prescription by treating physician and custom fabrication; absence of TMJ dysfunction or periodontal disease required.
Pediatric OSA
Pediatric polysomnography indications and thresholds
PSG for initiation/titration of CPAP in children: AHI/RDI ≥5, or AHI/RDI ≥1.5 with excessive daytime sleepiness/behavioral problems/hyperactivity.
Surgical coverage prerequisites / Non-CPAP candidacy
Covered when ALL of the following are met for consideration of surgical management:
Conservative measures include weight loss, sleep-position measures, avoidance of alcohol/sedatives, oral appliances, and medically supervised smoking cessation as applicable.
Polysomnogram data elements required are detailed in policy documentation guidance.
These non-CPAP candidacy items are recognized pathways for consideration of surgery or alternative management per policy updates.
Diagnostic sleep testing is not medically necessary when intended solely to evaluate non-OSA conditions that can be diagnosed by other means. Examples explicitly listed include: bruxism, drug dependency, enuresis, insomnia, night terrors, nocturnal myoclonus, restless leg syndrome, shift work/schedule disturbances, somnambulism, migraine headaches, and snoring without other signs or symptoms of OSA.
The policy excludes coverage of several devices and services. Specifically, over-the-counter bite guards are not covered. Continuous positive airway pressure (CPAP) is not covered when the policy’s diagnostic and medical criteria are not met. Treatment directed at snoring without clinically significant OSA is considered not medically necessary. Additionally, a number of therapies are identified as investigational or not covered, including atrial pacing, nasal EPAP devices, single‑pressure oral airway devices without forced nasal airflow, palate and mandible expansion devices, abbreviated daytime PAP acclimation sessions (PAP‑NAP), sleep positioning trainers with vibration, and daytime electrical stimulation of the tongue.
Treatment of simple snoring in the absence of documented obstructive sleep apnea is deemed not medically necessary and therefore not covered. The policy explains that snoring alone is not considered an illness or disease meeting medical necessity criteria; consequently surgical or procedural interventions aimed solely at snoring are not supported under this policy.
The policy lists additional therapies and procedures that are either investigational or not medically necessary for snoring or OSA/UARS. Examples called out include: palatal implants and other palatal stiffening procedures (e.g., Pillar procedure, CAPSO), laser‑assisted uvulopalatoplasty (LAUP), radiofrequency volumetric tissue reduction (RFVTR/somnoplasty) of the soft palate or nasal turbinates, cautery‑assisted palatal stiffening, injection snoreplasty, the Repose system, and other nasal or palatal procedures when used for snoring alone.
Concise policy position: Snoring without documented obstructive sleep apnea is not medically necessary to treat. Interventions directed solely at snoring are not covered because snoring alone does not meet the policy’s definition of medical necessity.
Palatal stiffening procedures, including implantation of palatal implants (for example, the Pillar procedure) and related palatal stiffening operations, are considered not medically necessary for treatment of snoring alone and are investigational for treatment of UARS or OSA.
Coding, Diagnostic Thresholds, and Key Metrics
| No codes listed |
| A7032 | HCPCS code added (referenced in historical updates) |
| A7033 | HCPCS code added (referenced in historical updates) |
| A7034 | HCPCS code added (referenced in historical updates) |
| A7035 | HCPCS code added (referenced in historical updates) |
| A7036 | HCPCS code added (referenced in historical updates) |
| A7037 | HCPCS code added (referenced in historical updates) |
| A7038 | HCPCS code added (referenced in historical updates) |
| A7039 | HCPCS code added (referenced in historical updates) |
| E0470 | HCPCS oxygen/CPAP-related code added |
| E0471 | HCPCS code added |
Provider Requirements, Documentation, and Prior Authorization
Confirm prior review rules and DME supplier eligibility for CPAP
Prior review requirements may apply per the member's Benefit Booklet and DME benefits; CPAP is covered under DME benefits. DME suppliers must meet the Plan's eligibility/credentialing requirements to be eligible for reimbursement.
- Check member Benefit Booklet for any prior review or benefit limitations for rental/purchase of CPAP equipment.
- Ensure DME supplier meets plan-defined eligibility/credentialing before billing for CPAP.
Attach medical necessity documentation for listed device/procedure codes
When submitting claims for devices or procedures listed in the policy, include documentation demonstrating medical necessity; inclusion of a code in the policy does not guarantee reimbursement.
- Custom fabricated OSA devices should be billed using E0486; include prescription and fabrication documentation when billing this code.
- Refer to the policy's Applicable Codes list (e.g., 42975, 94660, 95782–95811, A70xx series, E0485/E0486, E0561/E0562, E0601, G0398–G0400, K1027/K1037, S8040, 0964T–0966T) and attach supporting medical necessity evidence.
Submit current PSG and supporting records for surgical approvals
For any surgical approval request, submit current polysomnogram data (initial study, any CPAP titration data, and other studies performed) and supporting medical records; generally the sleep study used for approval must be less than 18 months old.
- Include the full PSG record (not just a summary) and supporting clinical notes.
- If prior surgical therapy exists, submit a repeat PSG when requested to support additional surgical therapy.
Document conservative therapy and CPAP titration/acclimation before alternatives
Conservative measures should be tried before initiating CPAP where appropriate, and CPAP titration plus documented acclimation and compliance efforts are required before alternative devices or surgery are covered.
- Document trials of weight loss, positional therapy, avoidance of alcohol/sedatives, and other conservative measures as clinically appropriate.
- Provide CPAP titration data and records of acclimation efforts (mask fitting, alternate interfaces, ramping, humidification, support) with compliance chip data.
Require CPAP trial and continuation attempts before oral appliance in severe OSA
Individuals with severe OSA should have an initial trial of CPAP and documented efforts to continue CPAP prior to switching to an oral appliance.
- Record CPAP trial details and attempts to maintain CPAP before authorizing oral appliance therapy for severe OSA.
Require failed conservative therapy and documented PAP attempts before surgery
Prior to surgical management, conservative measures appropriate to the clinical situation and a good-faith effort at positive airway pressure (CPAP/BiPAP) must be tried and failed; documentation of ongoing management by a sleep specialist for 3 months or greater may be required.
- Document attempts and failures of CPAP/BiPAP, including acclimation efforts and any compliance program participation.
- Include sleep specialist notes showing management for ≥3 months when relevant to a surgical request.
Ensure interpreter qualifications and include required clinical documentation elements
Documentation must confirm the testing modality and that the interpreting physician meets sleep medicine qualifications (ABSM certification, ABMS subspecialty certification, completion of required training pending first exam, or active staff membership of an AASM- or Joint Commission-accredited sleep center). Medical records must document symptoms (e.g., Epworth score), prior CPAP trials, device prescriptions, custom fabrication details for oral appliances, absence of TMJ/periodontal disease, and CPAP acclimation and compliance data.
- Include interpreter credentials per the four accepted verification options listed in the policy.
- Provide objective symptom documentation (e.g., pre-treatment Epworth >10 when relevant) and CPAP compliance chip readouts when claiming CPAP failure.
Provide complete medical records on request; letters alone may be insufficient
BCBSNC may request full medical records to determine medical necessity; letters of support alone are insufficient unless they contain all specific information needed for the medical necessity determination.
- When records are requested, provide complete study reports, clinician notes, device prescriptions, and compliance data rather than standalone letters.
Include required PSG report elements (TST, AHI/RDI, O2 metrics, desaturation durations)
Polysomnogram reports must include total sleep time; total RDI or AHI; average and lowest recorded oxygen saturation; for desaturations below 90%, the length of time at that saturation; obstructive event indices for supine and non-supine positions with total time supine; periodic limb movement index; and for CPAP titrations: optimum pressure, event index at that pressure, and total sleep time on CPAP.
- Ensure PSG report contains all listed elements when submitting for treatment authorization or surgical consideration.
Submit complete sleep study data; PSGs that omit positional event distinction may be insufficient
The Plan may require the complete polysomnogram data (not just summaries); a PSG that does not distinguish between supine and non-supine obstructive events may be incomplete and insufficient to support surgical requests.
- Provide full study records when requested and ensure positional event indices are reported to support surgical indications.
Denial risk when medical criteria or testing indications are not met
Treatments including CPAP, oral appliances, and surgical interventions will be denied when the policy's medical criteria and guidelines are not met; diagnostic testing for non-OSA conditions listed in the policy (e.g., bruxism, insomnia, restless leg syndrome, snoring without OSA) is not medically necessary.
- Do not submit claims for CPAP or other therapies unless objective criteria (AHI thresholds, symptom documentation, provider qualifications) in the policy are satisfied.
- Avoid requesting unattended sleep testing for conditions explicitly listed as not medically necessary.
CPAP and snoring-only treatments are noncovered if criteria unmet
CPAP is not covered when medical criteria and guidelines are not met; treatments for snoring without documented clinically significant OSA are considered not medically necessary and will be denied.
- Ensure diagnostic thresholds and required symptom documentation are met before requesting CPAP coverage.
- Do not bill for snoring-only interventions absent documented OSA per policy definitions.
Missing current PSG data may lead to denial of surgical requests
Surgical requests may be denied if current polysomnogram data (initial study, CPAP titration data, and other studies) are not submitted; generally the study upon which approval is requested must be less than 18 months old.
- Include the initial PSG, any CPAP titration study, and other relevant studies when requesting surgical authorization to avoid denial for incomplete documentation.
Background and Scope
Background: Sleep apnea comprises obstructive, central, and complex forms. Obstructive sleep apnea (OSA) is characterized by repetitive upper‑airway obstruction during sleep that leads to fragmented sleep and excessive daytime sleepiness. Diagnostic polysomnography with EEG‑based sleep staging is the gold standard; appropriately configured home sleep apnea tests may be used in selected adults when policy criteria are met. Clinical assessment, objective testing, and defined event indices (for example, Apnea‑Hypopnea Index thresholds) guide treatment decisions.
Definitions and Diagnostic Criteria
Policy Revision History
Specialty Matched Consultant Advisory Panel review with multiple updates; added HCPCS codes A7032–A7039, E0470–E0472, E0561–E0562, S2080; removed CPT codes 42825 and 42826 and several deleted HCPCS codes; notification given 10/14/04, effective 12/23/04.
Added 2005 CPT code 0088T to the Billing/Coding section for treatment of sleep apnea and breathing related sleep disorders in adults.
Added HCPCS codes K0553, K0554 and K0555 effective July 1, 2007.
Removed deleted HCPCS codes K0553–K0555 and added replacement codes A7027, A7028 and A7029 to Billing/Coding.
Notification that original Sleep Apnea policy was separated into three policies; new policy entitled 'Sleep Apnea: Diagnosis And Medical Management' (effective March 30, 2010).
Added CPT codes 0203T and 0204T to the Billing/Coding section for the new policy effective March 30, 2010.
Added CPT codes 95800 and 95801 to the Billing/Coding section and deleted codes 0203T and 0204T.
Added code A7047 to the Billing/Coding section.
Deleted HCPCS code S8262 and clarified prescribing language for oral appliances in the policy; policy noticed 10/1/15 for effective 12/30/15.
Policy statements revised to adopt 'home sleep apnea test' terminology and clarified adequate HSAT sensor requirements (minimum 3 sensors or PAT+oximetry+actigraphy); specialty panel review 8/21/2019.
Clarified risk language for HSATs and modified Policy Guidelines language regarding sensor requirements and risk categories; 'moderate' risk terminology updated.
Added new HCPCS code K1027 to the Billing/Coding section effective 10/1/2021.
Added CPT code 42975 to the Billing/Coding section; policy remained on notification until 2/22/2022.
Added new codes K1028 and K1029 to the Billing/Coding section (noted 3/31/22).
Added new HCPCS code A7049 to the Billing/Coding section effective 4/1/2023.
Removed HCPCS codes K1001, K1028, and K1029 from the Billing/Coding section.
Added HCPCS code K1037 to the Billing/Coding section, effective 4/1/2024.
Description updated and language changed from 'patient' to 'individual' throughout the policy; specialty panel and medical director reviews noted with no change to policy statement.
Updated Billing/Coding section to add CPT codes 0964T, 0965T, and 0966T effective 7/1/2025 (documented in implementation notes).
Added statement to Billing/Coding: 'Custom fabricated OSA devices should be billed using code E0486.'; specialty panel and medical director review March 2026; no change to policy statement.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.